HAE

Haemonetics CorporationNYSEHealthcare

$56.83+1.05%ClosedMarket Cap: $2.66B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	Citigroup	—	Neutral	—
2026-02-06	Mizuho	—	Outperform	—
2026-02-06	Citigroup	—	Neutral	—
2026-02-06	BTIG	—	Buy	—
2026-02-06	Barrington Research	—	Outperform	—
2025-12-17	Mizuho	—	Outperform	—
2025-12-15	Baird	—	Outperform	—
2025-12-15	Needham	—	Hold	—
2025-12-12	JP Morgan	—	Neutral	—
2025-12-11	Citigroup	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Mon Mar 29	$5.32	$1.39B	8
Wed Mar 29	$5.93	$1.49B	5
Thu Mar 29	$6.90	$1.64B	3
Fri Mar 29	$7.66	$1.76B	3